化学
药物发现
丝氨酸
膦酸盐
细胞毒性
蛋白酵素
抗生素
酶
丝氨酸水解酶
亚胺培南
活动站点
生物化学
组合化学
立体化学
微生物学
药理学
抗生素耐药性
体外
生物
作者
Orville A. Pemberton,Priyadarshini Jaishankar,Afroza Akhtar,Jessie L. Adams,Lindsey Neil Shaw,Adam R. Renslo,Yu Chen
标识
DOI:10.1021/acs.jmedchem.9b00728
摘要
Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam antibiotics. Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2. The most potent lead, compound 16, exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2. Compound 16 potentiated imipenem efficacy against resistant clinical and laboratory bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concentrations above 100 μg/mL. Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes. These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-negative pathogens and more generally highlight the active site features of carbapenemases that can be leveraged for lead discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI